Chromanol, quinone or hydroquinone compounds for treatment of sepsis

Hjalmar Roland Bouma (Uitvinder), Guido Krenning (Uitvinder), Robert Henk Henning (Uitvinder), Adrianus Cornelis van der Graaf (Uitvinder)

Onderzoeksoutput

16 Downloads (Pure)

Samenvatting

The invention relates to certain chromanol, quinone or hydroquinone compounds and derivatives thereof for treatment of sepsis and sepsis-induced organ dysfunction. Specifically, the present invention relates to chromanol compounds chosen from S-(6-hydroxy-2,5,7,8- tetramethylchroman-2yl)(piperazin-1-yl)methanone and S-(6-hydroxy-2,5,7,8- tetramethylchroman-2-yl)(4-(2-hydroxyethyl)piperazin-1-yl)methanone, and pharmaceutically acceptable salts thereof.
Originele taal-2English
OctrooinummerWO2021246868
Prioriteitsdatum02/06/2020
Indieningsdatum02/06/2021
StatusPublished - 9-dec.-2021

Vingerafdruk

Duik in de onderzoeksthema's van 'Chromanol, quinone or hydroquinone compounds for treatment of sepsis'. Samen vormen ze een unieke vingerafdruk.

Citeer dit